Search

everythinglearnresearchcommunity

for

Search:↓

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Certain Dibenzo derivatives may help treat prostate cancer.

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

Prepubertal girls with hypertrichosis have more sensitive androgen receptors, leading to increased body hair growth.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Clascoterone 1% cream is a promising new treatment for acne.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Clascoterone may be an effective topical treatment for hair loss.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Caribine from traditional Chinese medicine may help treat hair loss.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.